PURPOSE. To elucidate a noninvasive method to qualify and identify cultured human corneal endothelial cells (cHCECs) devoid of cell-state transition and adaptable for cell-based therapy.
A lthough human corneal endothelial cells (HCECs) have the ability to proliferate in vitro, 1 culturing HCECs for an extended period of time is known to be extremely difficult. 2 To date, most researchers have conceptualized cultured HCECs (cHCECs) only from the aspect that they are derived from corneal endothelium tissue, and disregarded details pertaining to the refinement of the biochemical features. In fact, cHCECs are known to be heterogeneous from culture to culture in their morphology and in their surface markers, such as cluster-ofdifferentiation (CD) antigens. [3] [4] [5] Studies, either directly or indirectly, and including those from Joyce et al., [6] [7] [8] [9] [10] [11] [12] [13] have shown that heterogeneity is present in HCEC cultures. Of particular and striking interest is the finding by Miyai et al. 3 of the presence of frequent chromosomal aneuploidy in cHCECs, directly indicating the presence of heterogeneous subpopulations (SPs) with or without aneuploidy.
Cultured HCECs have an inclination toward cell-state transition (CST) into a senescence phenotype, epitheliummesenchymal transition (EMT), and fibroblastic cell morphology. In addition, the plasticity of metabolic profiles of cHCECs might possibly interfere with the simple interpretation of heterogeneous SP composites in cHCECs. 14 One specific cHCEC SP with surface markers CD166 þ , CD133 À was revealed to be the SP without CST among heterogeneous cHCEC SPs. 15 This finding makes it possible to adapt this SP in the clinical setting, and the combination of CD markers defined in this study was found to be the most appropriate for quality control to ensure the functional characteristics of cHCECs. However, the flow cytometry application impedes cultured cells by scraping out cells for analysis, forcing us to seek a new noninvasive way to discriminate the quality of heterogeneous cHCEC SPs.
MicroRNAs (miRNAs or miRs) are noncoding RNAs that function as an endogenous regulator of gene expression. The dysregulation of miRNA has been implicated in the pathogenesis of diverse diseases. Moreover, a growing volume of evidence suggests that miRNAs play a critical role in various biologic processes, including cell proliferation, development, and differentiation. 16, 17 The expression of miRNAs is essential in the regulation of many cellular processes including the iovs.arvojournals.org j ISSN: 1552-5783
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This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. formation, maintenance, and remodeling of the extracellular matrix (ECM), 18 which is linked to CST in cHCECs. However, only three reports of miRNA expression concerning corneal endothelium have been published, and no information on cHCECs is available to date. Matthaei et al. 19 reported the widespread downregulation of miRNA levels in the corneal endothelium of patients with late-onset Fuchs' endothelial corneal dystrophy (FECD), and indicated significant downregulation of the miR-29 family. Zhao et al. 20 identified miRNAs differentially expressed in the corneal endothelium during aging. In addition, Iliff et al. 21 described the single-base-pair substitution in miR-184 in regard to the disease phenotype of EDICT, a syndrome characterized by endothelial dystrophy, iris hypoplasia, congenital cataract, and stromal thinning.
In the present study, the 3D-Gene miRNA Microarray Platform (Toray Industries, Inc., Tokyo, Japan) and hierarchical clustering revealed a distinct expression pattern of miRNAs in a comparative analysis of cHCECs with distinct phenotypes. Moreover, a unique miRNA expression pattern including upand downregulated miRNA clusters was revealed in cultured cells. In addition, our findings revealed that some isoforms of miR were also greatly upregulated in corneal endothelium tissues, while they were dramatically decreased in the tissue with pathogenically progressed gutatta. This observation may provide new insights on the pathogenesis of bullous keratoplasty (BK), including FECD.
MATERIALS AND METHODS

HCEC Donors
The human tissue used in this study was handled in accordance with the tenets set forth in the Declaration of Helsinki. Human CECs were obtained from more than 20 human donor corneas and were cultured before performance of karyotyping analysis. Human donor corneas were obtained from SightLife, Inc. (Seattle, WA, USA). Informed written consent for eye donation for research was obtained from the next of kin of all deceased donors. All tissues were recovered under the tenets of the Uniform Anatomical Gift Act (UAGA) of the particular state in which the donor consent was obtained and the tissue was recovered.
The donor age ranged from 2 to 75 years (mean age: 43.7 6 26.4 years). All donor corneas were preserved in Optisol GS (Chiron Vision, Inc., Irvine, CA, USA) and imported via international air transport for research purposes. Donor information accompanying the donor corneas showed that they were all considered healthy and free of any corneal disease, and that all donors had no past history of chromosomal abnormality. For the analysis of corneal endothelium tissues with gutatta, the tissues with an endothelial cell density (ECD) below 2000 cells/mm 2 (down to 380 cells/mm 2 ) were used and compared with tissues at the same age range.
Cell Culture of HCECs
Unless otherwise stated, the HCECs were cultured according to the published protocols, with some modifications. 4 Human donor corneas at the distinct ages were used for the experiments. Briefly, the Descemet's membranes with the CECs were stripped from donor corneas and digested at 378C with 1 mg/mL collagenase A (Roche Applied Science, Penzberg, Germany) for 2 hours. The HCECs obtained from a single donor cornea were seeded in one well of a type I collagen-coated six-well plate (Corning, Inc., Corning, NY, USA). The culture medium was prepared according to published protocols. Briefly, basal medium was prepared with OptiMEM I (Life Technologies Corporation, Carlsbad, CA, USA), 8% fetal bovine serum (FBS), 5 ng/mL epidermal growth factor (EGF; Life Technologies Corporation), 20 lg/mL ascorbic acid (Sigma-Aldrich Corp., St. Louis, MO, USA), 200 mg/L calcium chloride (Sigma-Aldrich Corp.), 0.08% chondroitin sulfate (Wako Pure Chemical Industries, Ltd., Osaka, Japan), and 50 lg/mL gentamicin. The HCECs were cultured using mesenchymal stem cell (MSC)-conditioned medium at 378C in a humidified atmosphere containing 5% CO 2 , and the culture medium was changed twice per week. When they reached confluence, the HCECs were passaged at ratios of 1:3 after treatment with 103 TrypLE Select (Life Technologies Corporation) for 12 minutes at 378C. The HCECs at passages 2 through 5 were used for all experiments. More than 70 cultures were set up for the analysis.
Phase-Contrast Microscopy
Phase-contrast microscopy images ware taken by use of an inverted microscope system (CKX41; Olympus Corporation, Tokyo, Japan).
Flow Cytometry Analysis of the cHCECs
Human CECs were collected from the culture dish by TrypLE Select treatment as described above and suspended at a concentration of 4 3 10 6 cells/mL in flow cytometry (FACS) buffer (phosphate-buffered saline containing 1% bovine serum albumin and 0.05% NaN 3 ). Next, an equal volume of antibody solution was added and incubated at 48C for 2 hours. The antibody solutions were as follows: FITC-conjugated antihuman CD26 mAb, PE-conjugated anti-human CD166 mAb, PerCP-Cy 5.5-conjugated anti-human CD24 mAb, PE-Cy 7-conjugated anti-human CD44 (all from BD Biosciences, San Jose, CA, USA), and APC-conjugated anti-human CD105 (eBioscience, Inc., San Diego, CA, USA). After washing with FACS buffer, the HCECs were analyzed by use of the BD FACSCanto II Flow Cytometry System (BD Biosciences).
3D-Gene Microarray Analysis
miRNA Extraction. Both corneal endothelial and epithelial tissues were stripped from donor corneas and then stored in QIAzol Lysis Reagent (Qiagen, Hilden, Germany) at À808C until total RNA extraction. Cultured HCECs were lysed by QIAzol Lysis Reagent and then stored at À808C until total RNA extraction. Total RNA was extracted by use of the miRNeasy Mini kit (Qiagen). The quality of the purified total RNA was analyzed by use of an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
miRNA Expression Profiling. Most of the experiments for the analysis of miRNA were carried out at least five times for each culture. For miRNA expression profiling, 3D-Gene Human microRNA Chips (miRBase versions 17-19; Toray Industries, Inc.) were used, 22 and 250 to 500 ng total RNA derived from both tissue and cell samples was labeled with Hy5 by use of the miRCURY LNA microRNA Power Labeling Kits (Exiqon A/S, Vedbaek, Denmark). The labeled miRNAs were individually hybridized onto the surface of the miRNA chips and then incubated at 328C for 16 hours. The washed and dried miRNA chips in an ozone-free environment were scanned using 3D-Gene Scanner 3000 (Toray Industries, Inc.) and analyzed using 3D-Gene Extraction Software (Toray Industries, Inc.).
Normalized Data Processing. The digitalized fluorescent signals provided by the above-described software were regarded as the raw data. All of the normalized data were globally normalized per microarray, such that the median of the signal intensity was adjusted to 25. In a case where a bar graph of tissue or cHCECs, normalized levels were adjusted to the 100th value agree from the high rank.
Polymerase Chain Reaction (PCR) Array. Total RNA was extracted from the cHCECs by use of the miRNeasy Mini kit (Qiagen). Complementary DNA synthesis was performed with 100 ng total RNA for a 96-well plate format by use of an RT 2 First Strand kit (Qiagen). Expression of endothelial mRNAs was investigated using the RT 2 Profiler PCR-Array Human Extracellular Matrix and Adhesion Molecules (EMA), Human p53 Signaling Pathway, Human Fibrosis, Human Cellular Senescence, and Human EMT (Qiagen), and then analyzed using RT 2 Profiler PCR Array Data Analysis Tool version 3.5 (Qiagen).
Statistical Analysis
Student's t-test was used to determine the statistical significance (P value) of the mean values for two-sample comparisons, and Dunnett's multiple-comparisons test was used to determine the statistical significance for the comparison of multiple sample sets. Values shown on the graphs represent the mean 6 SE.
RESULTS
Distinct miR Expression Profiles Among cHCEC Cultures
In this study, we dealt with improved cultures of cHCECs mostly without conspicuous EMT. However, it is difficult to discriminate the presence of a trace amount of EMT among heterogeneous SPs. At first, we compared the profiles of miRs detected by 3D-Gene between a CD44-SP (effector cell, lot 66P5 in Fig. 1A ) and several cultured cells not clear regarding their composition of SPs (lots 29, 34, and 35, all at passage 1). A slight upregulation in miR29c expression and decrease in miR-378 expression were found in the latter SPs compared with the CD44 À effector cells. Next, the effector CD44 À SP was compared with cultured cell lot 67 evident in CST (Fig. 1B) , whose composition of SPs is shown in Figure 2 . That comparison also revealed a downregulation in the miR-378 family. However, the comparison with cultured cell lot C11, also evident in CST but different from that of lot 67, did not reveal a downregulation of the miR-378 family (Fig. 1C) . These findings clearly indicate the presence of at least two different types of CST in cHCECs, even in the absence of conspicuous EMT. The expression profiles of the miR-378 family are summarized in Tables 1 and 2 . The striking reduction of miR-378 expression levels from cHCEC lot 66 was confirmed in morphologically distinguishable cultures of poor quality, and the expression levels of the miR-378 family were comparable between cell cultures 66 and C11.
miR Expression Profiles Among SPs With Distinct CD Markers
In an aim to elucidate the dependency of expression profiles of miRs on the composites of SPs distinct in their CD marker expression levels such as CD44, RNA extracted from FACSdefined cHCEC SPs (Fig. 2) was used for 3D-Gene analysis. To compare the miR profiles among cHCECs distinct in their CD44 expression status, we selected distinct culture methods to skew the composition of SPs in cHCECs. In the presence of SB431542 in our culture condition, we got different dominancy of CD44 þþþ cHCECs with distinct morphologic phenotypes shown in Figure 2C , a2. These three cHCECs, that is, a5, a1, and a2, contain SPs mainly composed of CD44 À CD24 À CD26 À , CD44 
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þþ SPs, respectively. As above, the expression levels of the miR378 family were comparable between a5 and a1, but a dramatic decrease was confirmed in a2 along the line with the elevated CD44 expression. The typical changes of miR-378a-3p, -378a-5p, and -378f are illustrated in Figure 3 . In addition to the miR378 family, the 23, 27, 30, 130, and 181 families inversely paralleled CD44 expression, whereas the 29, 31, 193, and 199 families positively paralleled CD44 expression (Fig. 3) . To clarify that situation, the changes were divided into five classes. As shown in Figure 3B , the inverse decrease of miR-378 family expression was gradual along the line with the increase of CD44. Thus, the changes did not discriminate the CST between a5 and a1 but did between a5 and a2. The most relevant finding is that the changes in expression level of miR34 between a5 and a1 is remarkable for discriminating the CST between them, although it did not do so between a1 and a2.
Quantitative reverse transcription PCR (qRT-PCR) also showed that the miR-378 family was most highly expressed. Simultaneously, miR1246 was downregulated in CD44-positive cells, whereas miR1273 and miR205 were upregulated in those cells (Fig. 4) .
Corneal Endothelial Tissue With Gutatta and miR-378 and 146
Considering the mimicry between in vitro CST, such as EMT and fibrosis, we next compared the miR profiles in fresh corneal endothelium tissues (Fig. 5A) . Scattered plots of miR expression profiles between tissues with normal levels of ECD with those of ECD378 more clearly demonstrated the upregulation of the miR378 family in corneal endothelium tissue than in corneal epithelium tissue (data not shown) but a dramatic decrease in low-ECD tissues accompanying advanced gutatta (Fig. 5B) . Conversely, miR146b-5p, whose expression level was far higher than in the miR378 family, was not reduced. Upregulation of the miR378 family was comparable between corneal endothelial and epithelial tissues (Fig. 5C) .
Next, five miRs were utilized to further validate the above findings. Quantitative RT-PCR also demonstrated that the expression of the miR378 family (a-3p, e, and f) was uniformly depressed in tissues with ECD 795 and 1410 (it should be noted that no RNA from the tissue with ECD 378 was available) (Fig. 5D) , whereas miR 200c, 205, and 124-5p were upregulated in those cells (data not shown).
Candidate Target of miR-378
Finally, we performed a preliminary transfection of miR-378a-3p or 5f mimics into CD44 þþþ cHCEC SP, in which the expression of these two was not detected. As shown in Supplementary Figure S1A , the gene signature of ECM and the adhesion molecules class was analyzed. Moreover, the cells showed the gene signature upregulated in many of the collagen, integrin (ITG), and matrix metalloproteinase (MMP) families as well as CD44. Supplementary Figure S1B shows the heat map of the gene signatures after transfection of two miR mimics as assayed by PCR arrays of senescence, EMT, fibrosis, p53, and EMA. We plan to present a more detailed analysis in the future. Some of the genes, such as CCNF, TWIST, and GADD45, were upregulated in the senescence array. Many genes showed distinct signatures in the p53 PCR array after transduction by miR-378f mimic, as well as the downregulation of TCF4, TCF3, TGFb2, TGFb3, and SOX10 in the EMT array.
DISCUSSION
Expansion of cHCECs from donor corneal endothelium could provide a pragmatic tool for the clinical application of cHCECbased therapy. Cultured HCECs expanded in an in vitro culture system can be a mixture of SPs with distinct CST, and the cultured cells tend to be inclined toward karyotype changes. 3 Thus, the purity of cHCECs should be carefully monitored from the aspect of heterogeneous SP composites with a view toward clinical applications, where it is vital that safety be ensured.
In the present study, not only the morphologic variations of cultured cells but also the composites of cHCEC SPs classified by CD markers varied greatly, even under seemingly similar morphologic figures, from culture to culture. Combined analysis of CD markers clearly specified the SPs (effector cells) adaptable for cell-based therapy among diverse SPs, and we successfully elucidated a method to quantitate the proportion of effector SPs in cultures (E-ratio). 15 The E-ratio is the ratio of the effector cells contained in cHCECs and suitable for cellinjection therapy. We defined the SP with CD133, CD105, CD90, CD44, CD26, CD24, and HLA-DR negative and CD166, HLA-ABC, and PD-L1 positive as effector cells, with complete absence of karyotype aneuploidy and with a CD marker profile consistent with that of HCECs in fresh corneal tissues.
The plasticity by morphologic and phenotypic conversions, such as expression of mesenchymal markers and loss of epithelial markers, is collectively referred to as EMT. Cultured HCECs have an inclination toward CST into EMT. Numerous miRNAs have been implicated in EMT (i.e., the miR-200, miR-34, and miR-203 families). In the comparison of the distinct cultures shown in Figure 1 , no evident changes in these EMTrelated miRs were detected, which is consistent with our judgment that our culture conditions exclude such conspicuous EMT. Conversely, and as summarized in Table 1 , many of the miR378 family were evidently downregulated in cultures heterogeneous in their SPs or with low E-ratios. In fresh human corneal endothelium (HCE) tissues, we observed contrasting features of miR signatures. MiRs relating to EMT were upregulated in HCE tissues with low ECD, as was the case for miR146 (also upregulated in tissues with advanced gutatta). The miR378 family was downregulated in cultures with low Eratios (Fig. 5) . In the context of the recently reported buffering effect of miRs against cell stresses, 23 the observed changes can be considered reasonable. Extensive regulatory loops have been described between promesenchymal transcription factors and epithelial-enforcing miRs. These operate not only to buffer the effects of stress on gene expression programs, but also to function as robust developmental reprogramming switches. 23 In the same context, the upregulation of miR146 in stressed HCE tissues may also be understandable. 24 Reportedly, miR-146a affects structural ECM proteins important in the assembly, composition, and organization of the ECM.
18 CD44 is known to be the key to distinguish differentiated cHCECs from either undifferentiated cells or cHCECs with CST by E-ratios. CD44 ablation increased metabolic flux to mitochondrial respiration and concomitantly inhibited entry into glycolysis. Such metabolic reprogramming, induced by CD44 ablation, reportedly results in a marked depletion of cellular reduced glutathione. 25 It is noteworthy that the only miR capable of discriminating CD44 À effector cells from CD44 þþ~C D44 þþþ SPs was identified as miR34a (Fig. 3B) . The miR34a downregulates the expression of CD44, and the miR-34a/CD44 axis activates the downstream factors of CD44, including Ras homolog gene family, member A (RhoA) and MMP-2. 26 In 2007, several groups identified the members of the miR-34 family as the most prevalent p53-induced miRNAs, and the members of the miR-34 family are now recognized as important mediators of tumor suppression. 27 Coincidentally, this is in accordance with our previous observation that the CD44 À effector SP only showed the absence of karyotype abnormality (Hamuro et al., unpublished data) .
The miR378 family showed a gradual decrease in parallel with decreases of CD44 expression (Fig. 3D) . MicroRNA-378 performs a metabolic shift leading to a reduction in tricarboxylic acid (TCA) cycle gene expression, as well as an increase in lactate production. 28 The miR-378 family is known to play roles in mitochondrial energy homeostasis. 28, 29 This indicates that the shift from aerobic oxidative metabolism to glycolytic metabolism is a characteristic feature of some CST in cHCECs. Pyruvate is processed by the TCA cycle through oxidative phosphorylation. Citrate/lactate ratios discriminated CD44 À effector cells not only from CD44 þþþ , but also from CD44 þþ SPs with a minuscule amount of CST. 30 Several miRs, including miR-378a-5p, have also been shown to be involved in senescence targeting the p53 pathway. Senescence induction could provide miR-378a-5p with an additional mechanism in regard to how it is involved in CST regulation in cHCECs. 31 ,32 
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The normalized value of miR378a-5p and 378f in corneal endothelial and epithelial tissues is depicted. The miR378f expression level was dramatically decreased in tissues with lowered ECD. (D) The normalized value of miR146a-5p and 146b-5p in corneal endothelial/epithelial tissues, cHCECs, and supernatants of cHCECs are shown. CSTþ means cHCECs with morphologically abnormal cells differing from CD44 À/þ . The miR146b-5p expression levels were uniformly upregulated during cultures. (E) Expression levels of miR-378a-3p, -378e, and -378f were evaluated by qRT-PCR. The miRs were extracted from fresh HCE tissues distinct in ages and ECDs (donor age: 54 years, donor ECD: 3107 cells/mm 2 
